Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
DBV Technologies
Biotech
Food allergy biotech DBV is running out of cash
DBV Technologies, a French biotech working on a treatment for food allergies, says it's running out of cash.
Max Bayer
Mar 8, 2024 10:30am
FDA slaps hold on DBV peanut allergy trial in call for changes
Sep 22, 2022 9:30am
DBV peanut allergy patch hits endpoint in phase 3 infant study
Jun 8, 2022 8:40am
DBV preps 200 layoffs after nasty FDA reaction to peanut patch
Jan 7, 2021 11:18am
FDA turns back DBV Technologies' peanut allergy patch for kids
Aug 4, 2020 12:28pm
FDA chief Scott Gottlieb steps down—Chutes & Ladders
Mar 8, 2019 9:00am
